Sanctuary Advisors LLC Invests $1.96 Million in DaVita Inc. $DVA

Sanctuary Advisors LLC acquired a new stake in shares of DaVita Inc. (NYSE:DVA) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 8,792 shares of the company’s stock, valued at approximately $1,956,000.

Other large investors have also added to or reduced their stakes in the company. Fifth Third Bancorp grew its holdings in shares of DaVita by 831.4% during the first quarter. Fifth Third Bancorp now owns 38,411 shares of the company’s stock valued at $5,903,000 after buying an additional 34,287 shares during the last quarter. Assenagon Asset Management S.A. raised its holdings in DaVita by 30.5% in the 2nd quarter. Assenagon Asset Management S.A. now owns 44,783 shares of the company’s stock worth $9,963,000 after acquiring an additional 10,477 shares during the last quarter. SG Americas Securities LLC lifted its position in DaVita by 27.4% in the 1st quarter. SG Americas Securities LLC now owns 212,293 shares of the company’s stock valued at $32,627,000 after acquiring an additional 45,609 shares in the last quarter. LSV Asset Management boosted its stake in DaVita by 1.1% during the 4th quarter. LSV Asset Management now owns 936,768 shares of the company’s stock valued at $106,426,000 after purchasing an additional 9,739 shares during the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S increased its holdings in shares of DaVita by 63.5% in the 4th quarter. BI Asset Management Fondsmaeglerselskab A S now owns 86,000 shares of the company’s stock worth $9,770,000 after purchasing an additional 33,394 shares in the last quarter. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Insider Activity at DaVita

In other news, insider Kathleen Alyce Waters sold 15,405 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $208.40, for a total transaction of $3,210,402.00. Following the completion of the sale, the insider owned 109,194 shares of the company’s stock, valued at $22,756,029.60. This represents a 12.36% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.90% of the stock is owned by insiders.

Wall Street Analyst Weigh In

DVA has been the subject of several recent analyst reports. TD Cowen upgraded DaVita from a “hold” rating to a “buy” rating and boosted their price target for the stock from $201.00 to $220.00 in a research note on Friday, August 7th. Oppenheimer set a $220.00 price objective on DaVita in a report on Friday, August 7th. Weiss Ratings upgraded shares of DaVita from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, August 5th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $265.00 price target on shares of DaVita in a report on Wednesday, August 5th. Finally, UBS Group lifted their price target on shares of DaVita from $235.00 to $270.00 and gave the stock a “buy” rating in a research note on Friday, July 10th. Four equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $221.75.

DaVita Price Performance

DVA stock opened at $180.34 on Thursday. DaVita Inc. has a 1 year low of $101.00 and a 1 year high of $247.49. The company has a market cap of $11.51 billion, a P/E ratio of 14.76, a price-to-earnings-growth ratio of 0.59 and a beta of 0.88. The stock’s fifty day moving average price is $213.07 and its 200-day moving average price is $182.80.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $4.02 EPS for the quarter, beating analysts’ consensus estimates of $3.88 by $0.14. The company had revenue of $3.55 billion during the quarter, compared to analysts’ expectations of $3.50 billion. DaVita had a negative return on equity of 217.63% and a net margin of 6.05%.DaVita’s revenue for the quarter was up 5.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.95 earnings per share. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, analysts expect that DaVita Inc. will post 14.57 earnings per share for the current year.

About DaVita

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.